← Back to Search

Educational Intervention for Breast Cancer Risk

N/A

Waitlist Available

Led By Kent Hoskins, M.D.

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No prior history of breast cancer

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test whether an educational intervention can help patients understand their cancer risk.

Who is the study for?

This trial is for African American women aged 25-69 who are recommended for genetic counseling based on a cancer risk assessment done during their mammogram at UI Health. They must not have had breast cancer before or previous genetic counseling for hereditary breast cancer risk, and they should be able to consent and complete surveys in English.Check my eligibility

What is being tested?

The study is testing the effectiveness of an educational video intervention used alongside a genetic risk assessment during mammography appointments to see if it increases the uptake of genetic counseling among participants.See study design

What are the potential side effects?

Since this trial involves an educational video as an intervention, there are no direct medical side effects associated with it. However, participants may experience emotional or psychological responses to learning about their breast cancer risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never had breast cancer before.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Knowledge and intentions regarding genetic counseling

Secondary outcome measures

Attendance at genetic counseling appointment

Trial Design

1Treatment groups

Experimental Treatment

Group I: Open LabelExperimental Treatment1 Intervention

Educational genetic counseling video

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Educational video

2014

Completed Phase 3

~3610

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

607 Previous Clinical Trials

1,558,396 Total Patients Enrolled

Kent Hoskins, M.D.Principal InvestigatorUniversity of Illinois at Chicago

1 Previous Clinical Trials

13 Total Patients Enrolled

Media Library

Open Label Clinical Trial Eligibility Overview. Trial Name: NCT04082117 — N/A

Breast Cancer Risk Research Study Groups: Open Label

Breast Cancer Risk Clinical Trial 2023: Open Label Highlights & Side Effects. Trial Name: NCT04082117 — N/A

Open Label 2023 Treatment Timeline for Medical Study. Trial Name: NCT04082117 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment open to adults aged sixty and above?

"To meet the requirements of this clinical trial, patients must be between 25 and 69 years old. Elsewhere on the site there are 64 studies recruiting participants below 18 years in age, as well as 2209 trials for people above 65."

Answered by AI

What qualifications must individuals possess to be accepted into this research program?

"The enrollment conditions for this medical trial mandate that participants must have a breast cancer diagnosis and be between 25 to 69 years old. The study is seeking 960 people in total."

Answered by AI

Are researchers presently recruiting for this investigation?

"According to clinicaltrials.gov, the study in question is no longer recruiting patients at this time; the first posting was on May 12th 2017 and its last update was June 22nd 2022. However, there are still 2,291 other trials actively enrolling participants as of now."

Answered by AI

Recent research and studies

BMC Health Services ResearchJournal

Pilot Study of a Culturally Sensitive Intervention to Promote Genetic Counseling for Breast Cancer Risk

Henderson, Vida, Jessica M. Madrigal, Le’ Chaun Kendall, Pooja Parekh, Jennifer Newsome, Ifeanyi Beverly Chukwudozie, De Lawnia Comer-Hagans, et al.. 2022. “Pilot Study of a Culturally Sensitive Intervention to Promote Genetic Counseling for Breast Cancer Risk”. BMC Health Services Research. Springer Science and Business Media LLC. doi:10.1186/s12913-022-08193-x.

clinicaltrials.govStudy

Uptake of Genetic Counseling Among African American Women

Kent F. Hoskins, MD 2017. "Uptake of Genetic Counseling Among African American Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04082117.